News

Home > News & Publications > News > Servier and PRISM BioLab enter drug discovery collaboration for a novel target

Servier and PRISM BioLab enter drug discovery collaboration for a novel target

Published on: June 16, 2021

PRISM BioLab provides PepMetics® (peptide mimetic small molecules) Technology for generating Hit and Lead compounds against Servier’s novel target.

Read Full Press Release

    PRISM is open to all levels of scientific discussion. Our scientists would love to speak with you!

    Scroll to top
    en_USEnglish
    jaJapanese en_USEnglish